Multiple sclerosis treatment approach developed at Mainz University moves toward clinical application
Grant and Award Announcement
Updates every hour. Last Updated: 28-Oct-2026 14:16 ET (28-Oct-2026 18:16 GMT/UTC)
A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application. The team led by Professor Claire Jacob at Johannes Gutenberg University Mainz (JGU) is further developing a drug patch that could promote the repair of damaged myelin sheaths. ForTra gGmbH for Research Transfer (ForTra), a subsidiary of the Else Kröner-Fresenius Foundation, is supporting the project with EUR 1.1 million. The aim is to further develop the patch for production according to pharmaceutical quality standards and subsequently assess its safety and tolerability in an initial clinical trial.
A new study published in Biomedical Analysis reports a protein-coated nanoparticle platform that combines the powerful light-to-heat conversion ability of copper sulfide with the biological compatibility of albumin, offering a potential strategy for safer photothermal cancer therapy.
Six years after COVID-19 disrupted childhood around the world, new research following the same children from before the pandemic through today finds that the damage was far less widespread than early warnings predicted. A Special Section in the Society for Research in Child Development's flagship journal Child Development, synthesizing 17 long-term studies across six countries, finds that most children's health, learning, social development, and wellbeing recovered substantially. Setbacks that persisted were concentrated among children who already faced other risks before the pandemic began. This new research, tracking children over a longer period, tells a different story: pandemic impacts were real and wide-ranging, but not as severe as initially feared, and many effects weakened over time. The children who fared worst and recovered more slowly were disproportionately those shaped by pre-existing risks — not the pandemic alone.
Twin studies place the heritability of schizophrenia near eighty percent, but concordance between monozygotic twins falls well short of fifty percent. What occupies the remaining distance is unresolved. Consuelo Walss-Bass, who directs the Psychiatric Genetics Program and the brain collection at UTHealth Houston, approaches the problem through transcriptomic and epigenetic profiling of donated brain tissue and through induced pluripotent stem cell models derived from families with multiple affected siblings. She also grew up with the question: her mother had schizophrenia, and of five children raised afterward in Torreón, Mexico, one received the same diagnosis. Why My Sister? sets the two accounts alongside each other.
A team of USC researchers is developing an AI-driven platform that aims to predict both risk factors and protective factors for depression and suicide using patterns in brain activity and behavior. The project, supported by a contract award of up to $4 million from the Advanced Research Projects Agency for Health (ARPA-H), will continuously monitor college student mental health through a combination of lab tests, wearable sensors and smartphone data. Its findings could help pinpoint when a mental health crisis is imminent and how best to intervene. The new study, known as Scalable Evaluation of Neurobehavioral Trajectories in Everyday Life (SENTINEL), will track approximately 210 USC students for up to 36 months. Study participants will be evenly split between three groups: students with no mental health concerns, students with depression, and students with depression that includes suicidal thoughts or behaviors. Once enrolled in SENTINEL, participants will complete a series of tasks and tests in the laboratory every six months. These include EEG (a measure of brain activity), eye tracking and detailed psychiatric questionnaires. They will also be given wearable devices, such as an Oura Ring or Fitbit, to gather additional data on their daily habits and well-being. These devices provide information on heart rate, heart rate variability, skin temperature, skin conductance (a measure of stress), blood oxygen levels, physical activity, and sleep stages and duration. In addition, students will complete weekly questionnaires through a smartphone app about their stress, anxiety, mood, overall well-being, and daily challenges and positive experiences. They will answer some questions by voice so researchers can analyze speech patterns. With consent, researchers will also collect smartphone data on app usage, communication patterns and attention. The study is designed to capture not just periods of distress, but also moments when students are doing well. Researchers aim to rapidly translate its findings into tools that can help clinicians identify risk and intervene early.
Study led by the NUS Yong Loo Lin School of Medicine identifies STMP1 as a key guardian of heart-cell mitochondria and a potential target for treating age-related heart failure